0001829049-20-000001.txt : 20201020 0001829049-20-000001.hdr.sgml : 20201020 20201020133525 ACCESSION NUMBER: 0001829049-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201020 DATE AS OF CHANGE: 20201020 EFFECTIVENESS DATE: 20201020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aristea Therapeutics, Inc. CENTRAL INDEX KEY: 0001829049 IRS NUMBER: 831074231 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-378342 FILM NUMBER: 201247909 BUSINESS ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-987-4064 MAIL ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001829049 Aristea Therapeutics, Inc. 12770 HIGH BLUFF DRIVE SUITE 380 SAN DIEGO CA CALIFORNIA 92130 858-987-4064 DELAWARE None None Corporation true 2018 James Mackay c/o Aristea Therapeutics, Inc. 12770 HIgh Bluff Drive, Suite 380 San Diego CA CALIFORNIA 92130 Executive Officer Director Tiba Aynechi c/o Aristea Therapeutics, Inc. 12770 HIgh Bluff Drive, Suite 380 San Diego CA CALIFORNIA 92130 Director Kenneth Harrison c/o Aristea Therapeutics, Inc. 12770 HIgh Bluff Drive, Suite 380 San Diego CA CALIFORNIA 92130 Director Ciara Kennedy c/o Aristea Therapeutics, Inc. 12770 HIgh Bluff Drive, Suite 380 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2020-10-06 false true false 0 62620986 39620984 23000002 $36,999,998.14 new money; $2,620,986.30 conversion of notes false 9 0 0 0 false Aristea Therapeutics, Inc. /s/ James Mackay James Mackay President 2020-10-20